ABG hires equity analyst to cover hearing health and pharmaceutical companies

Morten Larsen will be the new equity analyst at ABG Sundal Collier, where he will be in charge of covering Coloplast, Demant, GN Store Nord, Lundbeck and Novo Nordisk.

Photo: Fabian Bimmer/Reuters/Ritzau Scanpix

ABG Sundal Collier has hired equity analyst Morten Larsen, who has worked at the Nordic investment bank before.

Larsen will join the bank's Copenhagen office on Sep. 20, and replaces Jannick Lindegaard Denholt, who leaves the role on Sep. 17, Senior Analyst at ABG Casper Bloms informs Bloomberg News.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs